miR‑106b‑5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma
Authors:
Open Access
- 6 March 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 19 (5) , 3203-3210
Abstract
MicroRNA (miR)‑106b‑5p has been reported to act as both an oncogene and tumor suppressor in several tumors. The aim of the present study was to investigate the biological function of miR‑106b‑5p in osteosarcoma (OS). miR‑106b‑5p expression was observed to be significantly increased in OS tissues and cell lines. MTT assay and flow cytometry analysis determined that miR‑106b‑5p inhibitor transfection suppressed OS cell proliferation and induced cell cycle G0/G1 phase arrest. Furthermore, bioinformatics analysis and a luciferase reporter assay demonstrated that cyclin‑dependent kinase inhibitor 1A (CDKN1A) was a potential target of miR‑106b‑5p. p21 protein expression was found to be significantly increased by miR‑106b‑5p downregulation in OS cells. Further analysis demonstrated that CDKN1A was downregulated in OS tissues and was negatively correlated with miR‑106b‑5p expression. Furthermore, upregulation of CDKN1A expression mimicked, whilst CDKN1A knockdown reversed the suppressive effects of miR‑106b‑5p inhibitor on OS cell proliferation and cell cycle progression. In summary, the present data suggested that miR‑106b‑5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in OS.Keywords
This publication has 34 references indexed in Scilit:
- The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1AThe International Journal of Biochemistry & Cell Biology, 2015
- Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cellsCell Death & Disease, 2015
- miRDB: an online resource for microRNA target prediction and functional annotationsNucleic Acids Research, 2014
- Cyclin-dependent kinasesGenome Biology, 2014
- Less understood issues: p21Cip1 in mitosis and its therapeutic potentialOncogene, 2014
- Osteosarcoma treatment – Where do we stand? A state of the art reviewCancer Treatment Reviews, 2014
- MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genesOncogene, 2013
- In hepatocellular carcinoma miR‐519d is up‐regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2The Journal of Pathology, 2012
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001